无对比剂简化MRI在超声VIS-C肝硬化患者中的可视化质量与HCC监测效果
回顾性纳入264例既往超声VIS-C的Child-Pugh A/B级肝硬化患者,评估无对比剂简化MRI(NC-AMRI)的肝脏可视化质量及早期HCC检出效果。结果显示DWI和T2WI上VIS-A或B分别达91.7%和95.1%,检出的18例HCC中94.4%为早期。
要点
- 超声VIS-C患者行NC-AMRI多数可获得足够可视化质量,DWI和T2WI上VIS-A/B分别达91.7%和95.1%。
- NC-AMRI检出的HCC中94.4%为早期,提示其用于超声VIS-C肝硬化患者HCC监测的有效性。
- 阅片时需关注DWI和T2WI的肝脏实质异质性、伪影及可视化范围对评分的影响。
局限性
- 回顾性研究设计。
- 原文指出结果需在更大规模、前瞻性、多中心队列中确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The recently updated Liver Imaging Reporting and Data System version 2024 Surveillance US algorithm introduced alternative strategies, including abbreviated MRI, for patients with repeat or at high risk for repeat US visualization score C (VIS-C) examinations. This study aimed to evaluate the liver visualization quality and the effectiveness of noncontrast-abbreviated MRI (NC-AMRI) for hepatocellular carcinoma (HCC) surveillance in cirrhotic patients with US VIS-C.
MATERIALS AND METHODS: This retrospective study included Child-Pugh class A or B cirrhotic patients with prior US VIS-C and who underwent NC-AMRI for HCC surveillance between December 2018 and July 2022. Two radiologists independently assessed the visualization quality based on liver parenchymal heterogeneity, artifacts, and liver visualization range, and assigned visualization scores (VIS-A, no or minimal limitations; VIS-B, moderate limitations; and VIS-C, severe limitations) on diffusion-weighted image (DWI) and T2-weighted image (T2WI) of NC-AMRI. Early-stage HCC detection was determined.
RESULTS: A total of 264 patients (mean age, 60.2 years; 169 men) were included. In NC-AMRI after US VIS-C, the visualization score on DWI was A in 60.6% (160/264), B in 31.1% (82/264), and C in 8.3% (22/264), and the visualization score on T2WI was A in 78.4% (207/264), B in 16.7% (44/264), and C in 4.9% (13/264). Of the 18 patients detected with HCCs in NC-AMRI, 17 patients (94.4%) had early-stage HCC.
CONCLUSION: NC-AMRI provided adequate visualization quality in more than 91% of cirrhotic patients with US VIS-C and demonstrated effectiveness for early-stage HCC detection.
KEY POINTS: Question What are the liver visualization quality and the effectiveness of noncontrast-abbreviated MRI (NC-AMRI) for hepatocellular carcinoma (HCC) surveillance in cirrhotic patients with US visualization score C (VIS-C)? Findings After US VIS-C, NC-AMRI achieved VIS-A or B in 91.7% on DWI and 95.1% on T2WI; among 18 HCCs detected, 94.4% were early stage. Clinical relevance NC-AMRI may provide acceptable liver visualization (DWI 91.7%, T2WI 95.1%) in US VIS-C cirrhosis and may facilitate early-stage HCC detection (94.4% early); findings warrant confirmation in larger, prospective, multi-center cohorts.
引用
- Yang HK, Lee S, Lee MY, et al. Visualization quality and effectiveness of noncontrast-abbreviated magnetic resonance imaging for hepatocellular carcinoma surveillance in cirrhotic patients with ultrasound visualization score C. Eur Radiol. 2026. PMID: 42622887. doi:10.1007/s00330-026-12822-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。